Spain Opioid Induced Constipation Market Growth Trends Regional Analysis Segmentation Application Restraints Key Players Profile Forecast To By 2024-2031 | AstraZeneca, Shionogi & Company, Limited, Takeda Pharmaceuticals Company Ltd

DataM Intelligence has released a new research report on the Spain Opioid Induced Constipation market. The report provides a detailed analysis of current and emerging trends, offering insights into the market dynamics. It utilizes Porter's Five Forces model to assess key factors such as supplier and customer relationships, risks from various agents, competitive intensity, and opportunities for new entrants. The study also includes research data from various companies, analyzing factors like benefits, gross margins, and strategic decisions in the global market. The report is enriched with tables, charts, and infographics for a clear presentation of the findings.

The Spain Opioid Induced Constipation Market is anticipated to reach at a CAGR 4.4% during the forecasting period (2024-2031).

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/spain-opioid-induced-constipation-market

Opioid-Induced Constipation (OIC) is a common and often debilitating side effect experienced by individuals who use opioid medications for pain management. Opioids, which include drugs like morphine, oxycodone, and hydrocodone, work by binding to specific receptors in the brain and spinal cord to relieve pain. However, they also affect the gastrointestinal (GI) tract, slowing down bowel motility and leading to difficulty in passing stools.

List of the Key Players in the Spain Opioid Induced Constipation Market:

AstraZeneca, Shionogi & Company, Limited, Takeda Pharmaceuticals Company Ltd, and Bausch Health Companies Inc.

Key Developments:

On June 19, 2019, Shionogi and Ferrer finalized a contract for the promotion of Rizmoic® (naldemedine) in Spain, a therapeutic agent designed to treat opioid-induced constipation.

In April 2019, Shionogi granted BioDelivery Sciences International, Inc. the rights to commercialize Symproic in the United States. This agreement includes an upfront cash payment of $20 million, an additional $10 million payable in six months, and ongoing quarterly royalty payments.

Also in April 2019, Shionogi entered into a distribution agreement with Sandoz for the sale of Rizmoic in key European markets, including Germany, the UK, and the Netherlands, specifically for adult patients who have previously been treated with a laxative. The contract includes a right of first refusal for additional European markets.

In July 2016, Bausch Health Companies Inc. launched RELISTOR Tablets, aimed at treating opioid-induced constipation (OIC) in adults suffering from chronic non-cancer pain.

Research Process:

Both primary and secondary data sources have been used in the global Spain Opioid Induced Constipation Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Segment Covered in the Spain Opioid Induced Constipation Market:

By Drug class: Mu-Opioid Receptor Antagonists (Naldemedine, Naloxegol, Methylnaltrexone), Chloride Channel Activators (Lubiprostone)

By Mode of administration: Oral, Parenteral

By Distribution channel: Hospital Pharmacies, Online pharmacies, Retail pharmacies

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/spain-opioid-induced-constipation-market

Regional Analysis:

➣ North America

➣ Asia-Pacific

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Spain Opioid Induced Constipation market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Spain Opioid Induced Constipation Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Spain Opioid Induced Constipation market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Spain Opioid Induced Constipation Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/spain-opioid-induced-constipation-market

The Research Report Offers Answers To The Following Questions:

☛ What is the expected growth rate of the global market for the forecast period?

☛ What are the key driving factors that are responsible to shape the fate of the Spain Opioid Induced Constipation market during the forecast period?

☛ What will be the overall size of the market during the analysis period?

☛ What are the prominent market trends which influence the development of the Spain Opioid Induced Constipation market across various regions?

☛ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?

☛ What are the challenges and threats that are likely to act as a barrier to the growth of the Spain Opioid Induced Constipation market?

☛ What are the major opportunities that the companies can get to attain success in the world?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.